Risk assessment of hyperglycaemia induced by steroid use for immunotherapy toxicity in non-small cell lung cancer (NSCLC) patients. (January 2020) - Elkonaissi, I.; Low, M.; Milner-Watts, C.; Laftah, Z.; Foreman, E.; Kabir, M.; Bhosle, J.; O'Brien, M.